Mereo BioPharma Announces FDA Clearance to Proceed into a Phase
MREO: Mereo BioPharma Group plc
2020-10-19 07:00:10
Mereo BioPharma Announces FDA Clearance to Proceed into a Phase 1b/2 study for Etigilimab (Anti-TIGIT)
2020-10-19 07:00:10
Mereo BioPharma Announces FDA Clearance to Proceed into a Phase 1b/2 study for Etigilimab (Anti-TIGIT)